China Guaifenesin (API) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Guaifenesin (API) market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Guaifenesin (API) market. Detailed analysis of key players, along with key growth strategies adopted by Guaifenesin (API) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Smart Pharm

    • Biesterfeld

    • Haizhou Pharma

    • Gennex Lab

    • Stellar Chemical

    • Camlin Fine Science

    • Seven Star Pharma

    • Iwaki Seiyaku

    • Delta Synthetic

    • Granules

    • Synthokem Labs

    • Yuan Cheng Group

    • Pan Drugs

    By Type:

    • 98%-99%

    • >99%

    By End-User:

    • Pharmaceuticals

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Guaifenesin (API) Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Guaifenesin (API) Market Size and Growth Rate of 98%-99% from 2016 to 2027

    • 1.3.2 China Guaifenesin (API) Market Size and Growth Rate of >99% from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Guaifenesin (API) Market Size and Growth Rate of Pharmaceuticals from 2016 to 2027

    • 1.4.2 China Guaifenesin (API) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Guaifenesin (API) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Guaifenesin (API) by Major Types

    • 3.4.1 Market Size and Growth Rate of 98%-99%

    • 3.4.2 Market Size and Growth Rate of >99%

    4 Segmentation of Guaifenesin (API) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Guaifenesin (API) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Guaifenesin (API) in Pharmaceuticals

    • 4.4.2 Market Size and Growth Rate of Guaifenesin (API) in Others

    5 Market Analysis by Regions

    • 5.1 China Guaifenesin (API) Production Analysis by Regions

    • 5.2 China Guaifenesin (API) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Guaifenesin (API) Landscape Analysis

    • 6.1 North China Guaifenesin (API) Landscape Analysis by Major Types

    • 6.2 North China Guaifenesin (API) Landscape Analysis by Major End-Users

    7 Central China Guaifenesin (API) Landscape Analysis

    • 7.1 Central China Guaifenesin (API) Landscape Analysis by Major Types

    • 7.2 Central China Guaifenesin (API) Landscape Analysis by Major End-Users

    8 South China Guaifenesin (API) Landscape Analysis

    • 8.1 South China Guaifenesin (API) Landscape Analysis by Major Types

    • 8.2 South China Guaifenesin (API) Landscape Analysis by Major End-Users

    9 East China Guaifenesin (API) Landscape Analysis

    • 9.1 East China Guaifenesin (API) Landscape Analysis by Major Types

    • 9.2 East China Guaifenesin (API) Landscape Analysis by Major End-Users

    10 Northeast China Guaifenesin (API) Landscape Analysis

    • 10.1 Northeast China Guaifenesin (API) Landscape Analysis by Major Types

    • 10.2 Northeast China Guaifenesin (API) Landscape Analysis by Major End-Users

    11 Southwest China Guaifenesin (API) Landscape Analysis

    • 11.1 Southwest China Guaifenesin (API) Landscape Analysis by Major Types

    • 11.2 Southwest China Guaifenesin (API) Landscape Analysis by Major End-Users

    12 Northwest China Guaifenesin (API) Landscape Analysis

    • 12.1 Northwest China Guaifenesin (API) Landscape Analysis by Major Types

    • 12.2 Northwest China Guaifenesin (API) Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Smart Pharm

      • 13.1.1 Smart Pharm Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Biesterfeld

      • 13.2.1 Biesterfeld Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Haizhou Pharma

      • 13.3.1 Haizhou Pharma Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Gennex Lab

      • 13.4.1 Gennex Lab Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Stellar Chemical

      • 13.5.1 Stellar Chemical Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Camlin Fine Science

      • 13.6.1 Camlin Fine Science Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Seven Star Pharma

      • 13.7.1 Seven Star Pharma Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Iwaki Seiyaku

      • 13.8.1 Iwaki Seiyaku Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Delta Synthetic

      • 13.9.1 Delta Synthetic Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Granules

      • 13.10.1 Granules Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Synthokem Labs

      • 13.11.1 Synthokem Labs Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Yuan Cheng Group

      • 13.12.1 Yuan Cheng Group Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Pan Drugs

      • 13.13.1 Pan Drugs Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Guaifenesin (API) Market Size and Growth Rate of 98%-99% from 2016 to 2027

    • Figure China Guaifenesin (API) Market Size and Growth Rate of >99% from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Guaifenesin (API) Market Size and Growth Rate of Pharmaceuticals from 2016 to 2027

    • Figure China Guaifenesin (API) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Guaifenesin (API) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Guaifenesin (API) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Guaifenesin (API)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Guaifenesin (API) by Different Types from 2016 to 2027

    • Table Consumption Share of Guaifenesin (API) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of 98%-99%

    • Figure Market Size and Growth Rate of >99%

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Guaifenesin (API) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Guaifenesin (API) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Pharmaceuticals

    • Figure Market Size and Growth Rate of Others

    • Table China Guaifenesin (API) Production by Regions

    • Table China Guaifenesin (API) Production Share by Regions

    • Figure China Guaifenesin (API) Production Share by Regions in 2016

    • Figure China Guaifenesin (API) Production Share by Regions in 2021

    • Figure China Guaifenesin (API) Production Share by Regions in 2027

    • Table China Guaifenesin (API) Consumption by Regions

    • Table China Guaifenesin (API) Consumption Share by Regions

    • Figure China Guaifenesin (API) Consumption Share by Regions in 2016

    • Figure China Guaifenesin (API) Consumption Share by Regions in 2021

    • Figure China Guaifenesin (API) Consumption Share by Regions in 2027

    • Table North China Guaifenesin (API) Consumption by Types from 2016 to 2027

    • Table North China Guaifenesin (API) Consumption Share by Types from 2016 to 2027

    • Figure North China Guaifenesin (API) Consumption Share by Types in 2016

    • Figure North China Guaifenesin (API) Consumption Share by Types in 2021

    • Figure North China Guaifenesin (API) Consumption Share by Types in 2027

    • Table North China Guaifenesin (API) Consumption by End-Users from 2016 to 2027

    • Table North China Guaifenesin (API) Consumption Share by End-Users from 2016 to 2027

    • Figure North China Guaifenesin (API) Consumption Share by End-Users in 2016

    • Figure North China Guaifenesin (API) Consumption Share by End-Users in 2021

    • Figure North China Guaifenesin (API) Consumption Share by End-Users in 2027

    • Table Central China Guaifenesin (API) Consumption by Types from 2016 to 2027

    • Table Central China Guaifenesin (API) Consumption Share by Types from 2016 to 2027

    • Figure Central China Guaifenesin (API) Consumption Share by Types in 2016

    • Figure Central China Guaifenesin (API) Consumption Share by Types in 2021

    • Figure Central China Guaifenesin (API) Consumption Share by Types in 2027

    • Table Central China Guaifenesin (API) Consumption by End-Users from 2016 to 2027

    • Table Central China Guaifenesin (API) Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Guaifenesin (API) Consumption Share by End-Users in 2016

    • Figure Central China Guaifenesin (API) Consumption Share by End-Users in 2021

    • Figure Central China Guaifenesin (API) Consumption Share by End-Users in 2027

    • Table South China Guaifenesin (API) Consumption by Types from 2016 to 2027

    • Table South China Guaifenesin (API) Consumption Share by Types from 2016 to 2027

    • Figure South China Guaifenesin (API) Consumption Share by Types in 2016

    • Figure South China Guaifenesin (API) Consumption Share by Types in 2021

    • Figure South China Guaifenesin (API) Consumption Share by Types in 2027

    • Table South China Guaifenesin (API) Consumption by End-Users from 2016 to 2027

    • Table South China Guaifenesin (API) Consumption Share by End-Users from 2016 to 2027

    • Figure South China Guaifenesin (API) Consumption Share by End-Users in 2016

    • Figure South China Guaifenesin (API) Consumption Share by End-Users in 2021

    • Figure South China Guaifenesin (API) Consumption Share by End-Users in 2027

    • Table East China Guaifenesin (API) Consumption by Types from 2016 to 2027

    • Table East China Guaifenesin (API) Consumption Share by Types from 2016 to 2027

    • Figure East China Guaifenesin (API) Consumption Share by Types in 2016

    • Figure East China Guaifenesin (API) Consumption Share by Types in 2021

    • Figure East China Guaifenesin (API) Consumption Share by Types in 2027

    • Table East China Guaifenesin (API) Consumption by End-Users from 2016 to 2027

    • Table East China Guaifenesin (API) Consumption Share by End-Users from 2016 to 2027

    • Figure East China Guaifenesin (API) Consumption Share by End-Users in 2016

    • Figure East China Guaifenesin (API) Consumption Share by End-Users in 2021

    • Figure East China Guaifenesin (API) Consumption Share by End-Users in 2027

    • Table Northeast China Guaifenesin (API) Consumption by Types from 2016 to 2027

    • Table Northeast China Guaifenesin (API) Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Guaifenesin (API) Consumption Share by Types in 2016

    • Figure Northeast China Guaifenesin (API) Consumption Share by Types in 2021

    • Figure Northeast China Guaifenesin (API) Consumption Share by Types in 2027

    • Table Northeast China Guaifenesin (API) Consumption by End-Users from 2016 to 2027

    • Table Northeast China Guaifenesin (API) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Guaifenesin (API) Consumption Share by End-Users in 2016

    • Figure Northeast China Guaifenesin (API) Consumption Share by End-Users in 2021

    • Figure Northeast China Guaifenesin (API) Consumption Share by End-Users in 2027

    • Table Southwest China Guaifenesin (API) Consumption by Types from 2016 to 2027

    • Table Southwest China Guaifenesin (API) Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Guaifenesin (API) Consumption Share by Types in 2016

    • Figure Southwest China Guaifenesin (API) Consumption Share by Types in 2021

    • Figure Southwest China Guaifenesin (API) Consumption Share by Types in 2027

    • Table Southwest China Guaifenesin (API) Consumption by End-Users from 2016 to 2027

    • Table Southwest China Guaifenesin (API) Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Guaifenesin (API) Consumption Share by End-Users in 2016

    • Figure Southwest China Guaifenesin (API) Consumption Share by End-Users in 2021

    • Figure Southwest China Guaifenesin (API) Consumption Share by End-Users in 2027

    • Table Northwest China Guaifenesin (API) Consumption by Types from 2016 to 2027

    • Table Northwest China Guaifenesin (API) Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Guaifenesin (API) Consumption Share by Types in 2016

    • Figure Northwest China Guaifenesin (API) Consumption Share by Types in 2021

    • Figure Northwest China Guaifenesin (API) Consumption Share by Types in 2027

    • Table Northwest China Guaifenesin (API) Consumption by End-Users from 2016 to 2027

    • Table Northwest China Guaifenesin (API) Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Guaifenesin (API) Consumption Share by End-Users in 2016

    • Figure Northwest China Guaifenesin (API) Consumption Share by End-Users in 2021

    • Figure Northwest China Guaifenesin (API) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Smart Pharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Smart Pharm

    • Figure Sales and Growth Rate Analysis of Smart Pharm

    • Figure Revenue and Market Share Analysis of Smart Pharm

    • Table Product and Service Introduction of Smart Pharm

    • Table Company Profile and Development Status of Biesterfeld

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biesterfeld

    • Figure Sales and Growth Rate Analysis of Biesterfeld

    • Figure Revenue and Market Share Analysis of Biesterfeld

    • Table Product and Service Introduction of Biesterfeld

    • Table Company Profile and Development Status of Haizhou Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Haizhou Pharma

    • Figure Sales and Growth Rate Analysis of Haizhou Pharma

    • Figure Revenue and Market Share Analysis of Haizhou Pharma

    • Table Product and Service Introduction of Haizhou Pharma

    • Table Company Profile and Development Status of Gennex Lab

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gennex Lab

    • Figure Sales and Growth Rate Analysis of Gennex Lab

    • Figure Revenue and Market Share Analysis of Gennex Lab

    • Table Product and Service Introduction of Gennex Lab

    • Table Company Profile and Development Status of Stellar Chemical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stellar Chemical

    • Figure Sales and Growth Rate Analysis of Stellar Chemical

    • Figure Revenue and Market Share Analysis of Stellar Chemical

    • Table Product and Service Introduction of Stellar Chemical

    • Table Company Profile and Development Status of Camlin Fine Science

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Camlin Fine Science

    • Figure Sales and Growth Rate Analysis of Camlin Fine Science

    • Figure Revenue and Market Share Analysis of Camlin Fine Science

    • Table Product and Service Introduction of Camlin Fine Science

    • Table Company Profile and Development Status of Seven Star Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seven Star Pharma

    • Figure Sales and Growth Rate Analysis of Seven Star Pharma

    • Figure Revenue and Market Share Analysis of Seven Star Pharma

    • Table Product and Service Introduction of Seven Star Pharma

    • Table Company Profile and Development Status of Iwaki Seiyaku

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Iwaki Seiyaku

    • Figure Sales and Growth Rate Analysis of Iwaki Seiyaku

    • Figure Revenue and Market Share Analysis of Iwaki Seiyaku

    • Table Product and Service Introduction of Iwaki Seiyaku

    • Table Company Profile and Development Status of Delta Synthetic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Delta Synthetic

    • Figure Sales and Growth Rate Analysis of Delta Synthetic

    • Figure Revenue and Market Share Analysis of Delta Synthetic

    • Table Product and Service Introduction of Delta Synthetic

    • Table Company Profile and Development Status of Granules

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Granules

    • Figure Sales and Growth Rate Analysis of Granules

    • Figure Revenue and Market Share Analysis of Granules

    • Table Product and Service Introduction of Granules

    • Table Company Profile and Development Status of Synthokem Labs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthokem Labs

    • Figure Sales and Growth Rate Analysis of Synthokem Labs

    • Figure Revenue and Market Share Analysis of Synthokem Labs

    • Table Product and Service Introduction of Synthokem Labs

    • Table Company Profile and Development Status of Yuan Cheng Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yuan Cheng Group

    • Figure Sales and Growth Rate Analysis of Yuan Cheng Group

    • Figure Revenue and Market Share Analysis of Yuan Cheng Group

    • Table Product and Service Introduction of Yuan Cheng Group

    • Table Company Profile and Development Status of Pan Drugs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pan Drugs

    • Figure Sales and Growth Rate Analysis of Pan Drugs

    • Figure Revenue and Market Share Analysis of Pan Drugs

    • Table Product and Service Introduction of Pan Drugs


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.